Reforming The Rx Rulers: A New Script For PBMs

As PBMs shift to value-based contracts, federal and state efforts seek to reduce drug costs, increase transparency and tackle anticompetitive practices.

Committee tasked with proposing major federal spending cuts. Will it have time for PBM reform? (Shutterstock)

More from Market Access

More from Market Intelligence